Shyam S. Bansal is a a cardiovascular immunologist with expertise in the immune-inflammatory pathways of myocardial infraction and heart failure. His research endeavors focus on the elucidation of innate (macrophages and dendritic cell) and adaptive (T-cells) immune responses during chronic heart failure and the role of these immune cells in mediating pathological left-ventricular remodeling. He is particularly interested in deciphering the role of T-cell subsets and time-dependent phenotypic changes that these cells undergo during chronic HF. He is also interested in identifying and developing novel therapeutic strategies to reverse pathological changes in the immune cells for their bench-to-bed transition. Shyam S. Bansal is an Assistant professor in the Department of Physiology and Cell Biology at the Ohio State University. He received a PhD from the Department of Pharmacology & Toxicology at the University of Louisville, Louisville, KY in 2011. Bansal's first post-doctoral training was in the Department of Nanotechnology at the Methodist Hospital Research Institute (09/2011-09/2012) followed by an extensive post-doctoral training (from 09/2012-07/2018) in studying the role of helper T-cells and Regulatory T cells in mediating pathological left-ventricular remodeling and ischemic heart failure.
'This is the 10th book of the Methods in Signal Transduction Series, which covers the role of immune cells and inflammatory pathways in relation to cardiovascular diseases. With over 30 authors, the book presents all aspects of the subject matter in a concise package. Researchers in the field of cardiology will find this collection a valuable reference.' - Massoud Mahmoudi, DO, PhD, University of California San Francisco